Background: HCV coinfection has been recognized as a possible contributor of poor CD4+ recovery under antiretrovirals (ART) and is known to promote systemic inflammation with accumulation of highly differentiated CD8+ T cells. We aimed to study immunological changes after direct-acting antiviral treatment (DAA) in HIV/HCV patients (pts) who achieved sustained virological response (SVR).
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocytes trajectories in HIV/HCV coinfected patients: data from the ICONA Foundation Cohort.
G. Nunnari;G. F. Pellicanò.
2018-01-01
Abstract
Background: HCV coinfection has been recognized as a possible contributor of poor CD4+ recovery under antiretrovirals (ART) and is known to promote systemic inflammation with accumulation of highly differentiated CD8+ T cells. We aimed to study immunological changes after direct-acting antiviral treatment (DAA) in HIV/HCV patients (pts) who achieved sustained virological response (SVR).File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
